Novo Nordisk | Stammkapital



Ordinary Share Capital Veränderung Datum
ANI Pharmaceuticals USD 2K 0 2024-12
Aurora Cannabis CAD 6.98B 907K 2024-12
Bausch Health Companies USD 10.51B 18M 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Canopy Growth CAD 8.67B 179.82M 2024-12
Corcept Therapeutics USD 136K 1000 2024-12
Drreddys Laboratories INR 834M 0 2024-12
Eli Lilly USD 592.6M 200K 2025-03
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Merck USD 1.79B 0 2024-12
Novartis USD 793M 0 2024-12
Novo Nordisk 446M 0 2024-09
Novo Nordisk DKK 446M 0 2024-09
Pacira USD 47K 0 2024-12
Perrigo USD 6.73B 30M 2024-12
Prestige Brands USD 559K 2K 2024-12
Supernus Pharmaceuticals USD 56K 1000 2024-12
Zoetis USD 5M 0 2024-12



Novo Nordisk Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.